Miyazaki Y, Kiguchi T, Sato S, Usuki K, Ishiyama K, Ito Y, Suzuki T, Taguchi J, Chiba S, Dobashi N, et al. Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial. International journal of hematology. 2022. 116. 2. 228-238
Asou C, ◎Maeda T, Ishikawa M, Okamura D, Kohri M, Takahashi N, Tsukasaki K, Sakaguchi H, Satoh T, Kayano H, et al. Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation. International journal of hematology. 2022. 115. 6. 898-901
Asou C, ◎Maeda T, Ishikawa M, Okamura D, Kohri M, Takahashi N, Tsukasaki K, Sakaguchi H, Satoh T, Kayano H, et al. Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation. International journal of hematology. 2022. 115. 6. 898-901
Asou C, ◎Maeda T, Ishikawa M, Okamura D, Kohri M, Takahashi N, Tsukasaki K, Sakaguchi H, Satoh T, Kayano H, et al. Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation. International journal of hematology. 2022. 115. 6. 898-901
Poor Prognostic Combination of Additional Chromosomal Abnormalities in Ph + ALL: JALSG Ph+ ALL TKI- SCT Study.
(64th American Society of Hematology Annual Meeting and Exposition 2022)
Familial extranodal NK/T-cell lymphoma: a case report and genetic analysis.
(第84回日本血液学会学術集会 2022)